Q&A: How 3PLs are navigating the latest pharma trends

As regulatory expectations rise and advanced therapies push cold-chain complexity, 3PLs are investing in validated infrastructure, network-wide quality systems, and data-driven visibility. Global pharma logistics services are shifting from store and ship to end-to-end commercialization support. As regulatory expectations rise and advanced therapies push cold-chain complexity, 3PLs are investing in validated infrastructure, network-wide quality systems, and data-driven visibility. Image credit: Cencora. Pharmaceutical third-party logistics (3PL) providers are moving beyond traditional warehousing into more holistic and strategic commercialization support. At the same time, rising demand for temperature-sensitive biologics and increasingly strict regulations necessitates 3PLs to build and scale advanced cold chain…

Source: Clinical Trials Arena